Results 191 to 200 of about 26,425 (258)

Functional profiling of porcine precision-cut lymph node slices as an <i>ex vivo</i> model for TLR-mediated and PCV2-specific immune responses. [PDF]

Front Immunol
Deosthali S, Marti-Garcia B, Harris H, Werling N, Noad R, Gerner W, Werling D.   +6 more
europepmc   +1 more source

Erosive vulvar lichen planus improved with topical ruxolitinib: A case report. [PDF]

SAGE Open Med Case Rep
Shaikh R, Kirshen C.
europepmc   +1 more source

A Flow Cytometry-Based Assay to Quantify the Binding of Transmembrane Ligands to Their Cognate Receptors Using Fluorescent Virus-Like Particles. [PDF]

Bio Protoc
Kim CM, Gaballa M, Lee D, Jouanguy E, Zhang SY, Casanova JL, Yatim A.   +6 more
europepmc   +1 more source

Ready-to-load MHC-I nanoparticles for high-throughput T cell screening studies. [PDF]

Sci Adv
Phan HAT, Eom S, Hwang D, Young MC, Sun SM, Erdman MC, Sun Y, Mallik L, Rotsides P, Painter MM, Wherry EJ, Monos DS, Sgourakis NG.   +12 more
europepmc   +1 more source

A novel approach to HPV16 VLP construction and production with improved accessibility and particle sorting potential. [PDF]

Front Mol Med
Williamson M, Boren C, Kumar R, Gollahon L.   +3 more
europepmc   +1 more source

Affinity Selection of MS2 VLPs as SARS-CoV-2 Vaccine Candidates Targeting Nucleocapsid Protein. [PDF]

Viruses
Peabody J, Ye C, Bradfute S, Chackerian B, Peabody DS.   +4 more
europepmc   +1 more source

Terminal V5 Tagging of All Four Newcastle Disease Virus Structural Proteins Is Compatible with Particle Formation in Sf9 Cells. [PDF]

Int J Mol Sci
Schweda A, Dauhalevich D, Rabalski L.
europepmc   +1 more source

A versatile VLP-mediated CRISPR-RNP platform for precise genome editing and durable epigenome silencing in cancer. [PDF]

Mol Ther Nucleic Acids
Ju S, Lee JH, Yang J, Jeong TY, Choi CG, Lee Y, Cha S, Park J, Kim SP, Kim S, Seong JK, Lee H, Kim K.   +12 more
europepmc   +1 more source